Tracked deals
9
9 tracked deals across 2019-2024.
Park City, Utah, United States
Formed in 2002, DW Healthcare Partners is a healthcare-focused private equity firm with over $2.7B in assets under management (as of 3/31/2026). The firm specializes in healthcare investments and value creation using a “true partnership” model focused on strategic growth initiatives and accelerating shareholder value.
Tracked deals
9
9 tracked deals across 2019-2024.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Growth capital
4 growth capital · 2 buyout · 1 addon
Last 6 years
Supporting Data
Med Learning Group (MLG), a continuing medical education provider, acquired Talem Health, an accredited medical education company focused on clinicians serving rural and underserved communities. The acquisition is supported by healthcare-focused private equity firm DW Healthcare Partners, with both organizations aiming to leverage synergies to expand reach and improve outcomes for vulnerable patient populations.
DW Healthcare Partners, a healthcare-focused private equity firm, completed an investment in LKC Technologies, maker of the handheld RETeval electroretinography/visual evoked potential device. The transaction positions LKC to scale its diagnostic medical-device business globally under new CEO Dina Dubey as founder Jim Datovech transitions from the CEO role.
DW Healthcare Partners completed an investment to acquire Med Learning Group (MLG), a former division of Ultimate Medical Academy, providing capital and strategic support to grow MLG's continuing medical education offerings. The transaction positions MLG to expand its online and in-person CME programs and measurement capabilities for pharmaceutical and provider customers.
DW Healthcare Partners completed a growth capital investment in Vets Plus, Inc. and Noble Pharma, LLC, backing the animal-health manufacturer to scale operations and expand pharmaceutical capabilities. As part of the transaction, Dave Nelson becomes President and CEO of Vets Plus while founder Raj Lall transitions from day-to-day management and remains on the board.
DW Healthcare Partners completed an investment in Bio Agri Mix LP, Canada’s largest manufacturer and distributor of medicated feed additives and water-soluble animal medications. As part of the transaction DWHP partners join Bio Agri Mix’s board and will support expansion of the company’s product portfolio and growth across the North American livestock market.
DW Healthcare Partners completed an investment in Parnell Pharmaceuticals Holdings Ltd, a fully integrated animal-health pharmaceutical developer and sterile-injectable manufacturer, and took seats on the company's board. DWHP said the capital and board expansion will support Parnell's growth in the U.S. and expansion of its product portfolio and manufacturing capabilities in animal health.
CareXM, a provider of virtual care and patient engagement solutions, has acquired TouchPointCare, a remote patient monitoring and telehealth platform. The deal expands CareXM’s at-home monitoring and patient engagement capabilities and is an add-on to the PE-backed CareXM platform.
DW Healthcare Partners, a healthcare-focused private equity firm, announced an investment in CareXM, a provider of virtual care and patient engagement solutions used by home health, hospice, physician practices and hospitals. The capital will support CareXM's continued product development and expansion of its 24/7 HIPAA-compliant virtual care and clinical nurse triage services across the United States.
DW Healthcare Partners (DWHP) announced a majority investment in CEFALY Technology SPRL, a Liège, Belgium–based manufacturer of neuro‑modulating medical devices for prevention and treatment of migraines. The investment—DWHP’s first from its fifth fund—will support CEFALY’s next stage of global growth and coincides with the appointment of Jen Trainor as CEO to scale marketing, sales and distribution.
Turn tracked acquisition activity into an outreach-ready buyer list.